Prestige Consumer Healthcare Inc. PBH
4 targets with a reported result
Releases of the last 3 yearsThe numbers PBH said it expected, in its earnings releases, next to what it then reported for the same period.
Target by target
Each target, with the sentence it came from · release and 10-Q or 10-K
| Target | What the company said | Reported | Result | |
|---|---|---|---|---|
| Diluted EPS (company-defined) Fiscal 2027 |
Given $4.55 to $4.65 release Aug 6, 2026
Lowered $4.48 to $4.55 release Nov 5, 2026
|
– | No standard number | |
The company's wordsRaising fiscal 2027 outlook to include acquisitions; anticipate revenue of $1,290 to $1,315 million and Adjusted Diluted EPS outlook to $4.55 to $4.65 release Aug 6, 2026 Updated Fiscal 2027 Outlook … Ron Lombardi, Chief Executive Officer, stated, "We are updating our fiscal 2027 outlook for revenues to $1,280 million to $1,290 million and adjusted diluted EPS of $4.48 to $4.55 primarily to reflect recent variability in Clear Eyes® production at Pillar5, which is expected to reduce product availability and revenue in the second half. release Nov 5, 2026 | ||||
| Revenue Fiscal 2027 |
Given $1.10B to $1.12B release May 13, 2026
Raised $1.29B to $1.31B release Aug 6, 2026
Lowered $1.28B to $1.29B release Nov 5, 2026
|
– | Not reported yet | |
The company's wordsFiscal 2027 Outlook … Revenue $1,100 million to $1,121 million release May 13, 2026 Raising fiscal 2027 outlook to include acquisitions; anticipate revenue of $1,290 to $1,315 million and Adjusted Diluted EPS outlook to $4.55 to $4.65 release Aug 6, 2026 Ron Lombardi, Chief Executive Officer, stated, "We are updating our fiscal 2027 outlook for revenues to $1,280 million to $1,290 million and adjusted diluted EPS of $4.48 to $4.55 primarily to reflect recent variability in Clear Eyes® production at Pillar5, which is expected to reduce product availability and revenue in the second half. release Nov 5, 2026 | ||||
| Diluted EPS (company-defined) Fiscal 2026 (ended Mar 31, 2026) |
Given $4.70 to $4.82 release May 8, 2025
Lowered $4.54 to $4.58 release Nov 6, 2025
|
– | No standard number | |
The company's wordsInitial fiscal 2026 organic revenue growth and Diluted EPS outlook of approximately 1% to 2% and $4.70 to $4.82, respectively release May 8, 2025 Fiscal 2026 revenue outlook unchanged; … Adjusted Diluted EPS outlook updated to $4.54 to $4.58, high end of previous range release Nov 6, 2025 | ||||
| Diluted EPS Fiscal 2026 (ended Mar 31, 2026) |
Given $4.50 to $4.58 release Aug 7, 2025
|
$3.91 10-K filed 2026-05-14 |
Below the range | |
The company's wordsRevising fiscal 2026 revenue outlook to $1,100 to $1,115 million and Diluted EPS outlook to $4.50 to $4.58 release Aug 7, 2025 | ||||
| Revenue Fiscal 2026 (ended Mar 31, 2026) |
Given $1.14B to $1.16B release May 8, 2025
Lowered $1.10B to $1.11B release Aug 7, 2025
Kept $1.10B to $1.11B release Nov 6, 2025
Lowered $1.10B release Feb 5, 2026
|
$1.09B 10-K filed 2026-05-14 |
Below the range | |
The company's wordsInitial Fiscal 2026 Outlook … Revenue $1,140 to $1,155 million release May 8, 2025 Revising fiscal 2026 revenue outlook to $1,100 to $1,115 million and Diluted EPS outlook to $4.50 to $4.58 release Aug 7, 2025 Prior Fiscal 2026 Current Fiscal 2026 Outlook Outlook … Revenue million $1,100 to $1,115 million release Nov 6, 2025 We are narrowing our fiscal 2026 net sales outlook to approximately $1.1 billion to reflect a continued challenging consumer environment while maintaining our outlook for free cash flow of $245 million or higher in fiscal 2026 which reflects our strong and stable financial performance. release Feb 5, 2026 | ||||
| Diluted EPS (company-defined) Fiscal 2025 (ended Mar 31, 2025) |
Given $4.40 to $4.46 release May 14, 2024
|
– | No standard number | |
The company's wordsInitial Full-Year Fiscal 2025 Organic Revenue Growth and EPS Outlook of Approximately 1% and $4.40 to $4.46, respectively release May 14, 2024 | ||||
| Revenue Fiscal 2025 (ended Mar 31, 2025) |
Given $1.12B to $1.14B release May 14, 2024
Kept $1.12B to $1.14B release Aug 8, 2024
Kept $1.12B to $1.14B release Nov 7, 2024
Lowered $1.13B to $1.13B release Feb 6, 2025
|
$1.14B 10-K filed 2025-05-09 |
Above the range | |
The company's wordsFiscal 2025 Outlook … Revenue $1,125 to $1,140 million release May 14, 2024 Fiscal 2025 Outlook … Revenue $1,125 to $1,140 million release Aug 8, 2024 Fiscal 2025 Outlook … Revenue $1,125 to $1,140 million release Nov 7, 2024 Prior Fiscal 2025 Current Fiscal 2025 Outlook Outlook … Revenue million $1,128 to $1,132 million release Feb 6, 2025 | ||||
| Revenue Fiscal 2024 (ended Mar 31, 2024) |
Given $1.14B to $1.14B release Feb 8, 2024
|
$1.13B 10-K filed 2024-05-15 |
Below the range | |
The company's wordsCommentary and Updated Outlook for Fiscal 2024 … We continue to anticipate revenues of $1,135 to $1,140 million, thanks to our diverse portfolio of brands. release Feb 8, 2024 | ||||
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (12 releases since 2024-02-08), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Sources
The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.
Also
Earnings releases: each release in full.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PBH/export.csv") into a cell.